Tag: Remdesivir

New Delhi: Union Health Minister Harsh Vardhan on Sunday said there will be a 10 times rise in Covaxin vaccine production by September while manufacture of remdesivir jabs, an anti-viral…

Mumbai: Spelling huge relief for lakhs of Covid-19 patients, the government has slashed the prices of the ‘life-saver’ Remdesivir injection by nearly 50 per cent, to MRP Rs 2,450 per…

New Delhi: Drug firm Hetero on Sunday said it has received approval from regulator DCGI to launch investigational antiviral drug Remdesivir for the treatment of COVID-19. Domestic pharma firm Glenmark Pharmaceuticals had on Saturday launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 at a […]

New York: Amid news that the US has bought up virtually the entire global supply of remdesivir, a new study outlines how the drug could save lives in countries with a lower hospital capacity, such as South Africa, where Covid-19 is beginning to overwhelm intensive care units (ICUs). The study, published in the journal Clinical […]

New Delhi: Doctors in state hospitals are being advised to use antiviral Remdesivir on COVID-19 patients strictly as per protocol amid some reports of liver damage in such patients treated with the drug, official sources said. While the health ministry is reviewing the guidelines on the usage of the drug following the adverse reports, states […]

New York: New data revealed by Gilead Sciences has shown that its antiviral drug remdesivir reduces death risk of severe Covid-19 patients by as much as 62 per cent when compared with standard care alone. This is an important finding that requires confirmation in prospective clinical trials, Gilead said on Friday about the results presented […]

Bengaluru: Global pharmaceutical company Mylan on Monday announced the commercial launch of the generic version of Gilead Sciences’s antiviral drug remdesivir under the brand name ‘DESREM’ in India to address urgent needs amid Covid-19. Available at a price of Rs 4,800 per 100mg vial, the drug costs more than 80 per cent less than the […]

New Delhi: Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory […]

Bhubaneswar: The Directorate of Drugs Control, Odisha today allowed the retail sale of Covid-19 drugs Remdesivir and Fevipiravir as per the directives of the Drugs Controller General India (DCGI). However, both the COVID drugs will be sold on certain conditions. DCGI has directed that the Fevipiravir tablets and Remdesivir injectable formulation will be sold under […]

New Delhi: The Supreme Court on Wednesday said the Centre has framed rules on drugs clinical trial and there is also an approval on the use of Remdesivir and Favipiravir as medicines to treat Covid-19. A bench headed by Chief Justice S A Bobde and comprising Justices A S Bopanna and V Ramasubramanian, citing the […]

New Delhi: The government has been alerted about the massive black marketing of Covid drug Remdesivir, which according to some evidence is selling for as high as Rs 50,000, over…

Bhubaneswar: Amid the confusion over the use of plasma therapy and Remdesivir for treating COVID-19 patients, Odisha Health Secretary Pradipta Mohapatra today clarified that the State is yet to receive any official statement from ICMR related to the ineffectiveness of the therapy or the use of the anti-viral drug in treating the infected patients. The […]

Washington: US regulators have given full approval for the antiviral drug remdesivir to treat the Covid-19 patients in hospitals. The US Food and Drug Administration (FDA) said Veklury, the drug’s brand name, cut the recovery time on average by five days during clinical trials. “Veklury is the first treatment for COVID-19 to receive FDA approval,” […]

Geneva: The World Health Organization (WHO) on Friday warned that the antiviral drug remdesivir should not be used to treat Covid-19 patients no matter how ill they are as there is no evidence it works. “The panel found a lack of evidence that remdesivir improved outcomes that matter to patients such as reduced mortality, need […]